- Home
- GMM vs NTRB Comparison
GMM vs NTRB Comparison
Compare GMM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GMM
- NTRB
- Stock Information
- Founded
- GMM 2017
- NTRB 2016
- Country
- GMM China
- NTRB United States
- Employees
- GMM N/A
- NTRB N/A
- Industry
- GMM
- NTRB Industrial Specialties
- Sector
- GMM
- NTRB Health Care
- Exchange
- GMM Nasdaq
- NTRB Nasdaq
- Market Cap
- GMM 61.9M
- NTRB 94.3M
- IPO Year
- GMM 2023
- NTRB N/A
- Fundamental
- Price
- GMM $2.61
- NTRB $7.12
- Analyst Decision
- GMM
- NTRB Buy
- Analyst Count
- GMM 0
- NTRB 1
- Target Price
- GMM N/A
- NTRB $13.00
- AVG Volume (30 Days)
- GMM 20.8K
- NTRB 172.5K
- Earning Date
- GMM 08-08-2025
- NTRB 09-02-2025
- Dividend Yield
- GMM N/A
- NTRB N/A
- EPS Growth
- GMM 62.17
- NTRB N/A
- EPS
- GMM 6.37
- NTRB N/A
- Revenue
- GMM $41,360,953.00
- NTRB $2,398,437.00
- Revenue This Year
- GMM N/A
- NTRB $560.75
- Revenue Next Year
- GMM N/A
- NTRB $588.39
- P/E Ratio
- GMM $0.41
- NTRB N/A
- Revenue Growth
- GMM 53.82
- NTRB 18.92
- 52 Week Low
- GMM $1.69
- NTRB $2.98
- 52 Week High
- GMM $15.60
- NTRB $9.42
- Technical
- Relative Strength Index (RSI)
- GMM 42.90
- NTRB 39.52
- Support Level
- GMM $2.53
- NTRB $8.00
- Resistance Level
- GMM $3.09
- NTRB $9.21
- Average True Range (ATR)
- GMM 0.25
- NTRB 0.63
- MACD
- GMM -0.02
- NTRB -0.16
- Stochastic Oscillator
- GMM 12.82
- NTRB 17.08
About GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.